Publicaciones en las que colabora con Gema Fruhbeck Martínez (32)

2023

  1. Antagonic effect of ghrelin and LEAP-2 on hepatic stellate cell activation and liver fibrosis in obesity-associated nonalcoholic fatty liver disease

    European journal of endocrinology, Vol. 188, Núm. 7, pp. 564-577

  2. Uroguanylin prevents hepatic steatosis, mitochondrial dysfunction and fibrosis in obesity-associated NAFLD

    Metabolism: Clinical and Experimental, Vol. 147

2022

  1. Transient elastography and serum markers of liver fibrosis associate with epicardial adipose tissue and coronary artery calcium in NAFLD

    Scientific Reports, Vol. 12, Núm. 1

2021

  1. Benefits of Bariatric Surgery Prior to SARS-CoV-2 Infection in Modulating the Response to COVID-19

    Obesity

  2. Obesity as an adipose tissue dysfunction disease and a risk factor for infections – Covid-19 as a case study

    European Journal of Internal Medicine, Vol. 91, pp. 3-9

2020

  1. Ghrelin Reduces TNF-α-Induced Human Hepatocyte Apoptosis, Autophagy, and Pyroptosis: Role in Obesity-Associated NAFLD

    Journal of Clinical Endocrinology and Metabolism, Vol. 104, Núm. 1, pp. 21-37

  2. Impact of Routine and Long-Term Follow-Up on Weight Loss after Bariatric Surgery

    Obesity Surgery, Vol. 30, Núm. 11, pp. 4293-4299

  3. Revisiting the Ghrelin Changes Following Bariatric and Metabolic Surgery

    Obesity Surgery, Vol. 30, Núm. 7, pp. 2763-2780

  4. Unravelling gender-specific factors that link obesity to albuminuria

    European Journal of Clinical Investigation, Vol. 50, Núm. 11

2019

  1. Adiponectin-leptin ratio is a functional biomarker of adipose tissue inflammation

    Nutrients, Vol. 11, Núm. 2

  2. Relevance of leptin and other adipokines in obesity-associated cardiovascular risk

    Nutrients, Vol. 11, Núm. 11

2018

  1. Clinical usefulness of abdominal bioimpedance (ViScan) in the determination of visceral fat and its application in the diagnosis and management of obesity and its comorbidities

    Clinical Nutrition, Vol. 37, Núm. 2, pp. 580-589

2017

  1. Eligibility and success criteria for bariatric/metabolic surgery

    Advances in Experimental Medicine and Biology (Springer New York LLC), pp. 529-543

  2. Fibroblast growth factor 15/19 (FGF15/19) protects from diet-induced hepatic steatosis: Development of an FGF19-based chimeric molecule to promote fatty liver regeneration

    Gut, Vol. 66, Núm. 10, pp. 1818-1828

  3. Involvement of the leptin-adiponectin axis in inflammation and oxidative stress in the metabolic syndrome

    Scientific Reports, Vol. 7, Núm. 1

2016

  1. Cardiovascular prevention in obese patients

    Current Pharmaceutical Design, Vol. 22, Núm. 37, pp. 5687-5697

  2. Does Preincisional Infiltration with Bupivacaine Reduce Postoperative Pain in Laparoscopic Bariatric Surgery?

    Obesity Surgery, Vol. 26, Núm. 2, pp. 282-288

  3. Factors related to increased resting energy expenditure in men with liver cirrhosis

    European Journal of Gastroenterology and Hepatology, Vol. 28, Núm. 2, pp. 139-145

  4. Increased interleukin-32 levels in obesity promote adipose tissue inflammation and extracellular matrix remodeling: Effect of weight loss

    Diabetes, Vol. 65, Núm. 12, pp. 3636-3648

  5. Metabolic Surgery Enters the T2DM Treatment Algorithm

    Trends in Endocrinology and Metabolism